Novel miR-5582-5p functions as a tumor suppressor by inducing apoptosis and cell cycle arrest in cancer cells through direct targeting of GAB1, SHC1, and CDK2
- Authors
- An, Hyun-Ju; Kwak, Seo-Young; Yoo, Je-Ok; Kim, Jae-Sung; Bae, In-Hwa; Park, Myung-Jin; Cho, Mee-Yon; Kim, Joon; Han, Young-Hoon
- Issue Date
- 10월-2016
- Publisher
- ELSEVIER
- Keywords
- MicroRNA; miR-5582-5p; Tumor suppressor; GABI; SHC1; CDK2
- Citation
- BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, v.1862, no.10, pp.1926 - 1937
- Indexed
- SCIE
SCOPUS
- Journal Title
- BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Volume
- 1862
- Number
- 10
- Start Page
- 1926
- End Page
- 1937
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/87356
- DOI
- 10.1016/j.bbadis.2016.07.017
- ISSN
- 0925-4439
- Abstract
- MicroRNAs (miRNAs) play pivotal roles in tumorigenesis as either tumor suppressors or oncogenes. In the present study, we discovered and demonstrated the tumor suppressive function of a novel miRNA miR-5582-5p. miR-5582-5p induced apoptosis and cell cycle arrest in cancer cells, but not in normal cells. GAB1, SHC1, and CDK2 were identified as direct targets of miR-5582-5p. Knockdown of GAB1/SHC1 or CDK2 phenocopied the apoptotic or cell cycle arrest-inducing function of miR-5582-5p, respectively. The expression of miR-5582-5p was lower in tumor tissues than in adjacent normal tissues of colorectal cancer patients, while the expression of the target proteins exhibited patterns opposite to that of miR-5582-5p. Intratumoral injection of a miR5582-5p mimic or induced expression of miR-5582-5p in tumor cells suppressed tumor growth in HCT116 xenografts. Collectively, our results suggest a novel tumor suppressive function for miR-5582-5p and its potential applicability for tumor control. (C) 2016 Elsevier B.V. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Life Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.